Vertex Pharmaceutic (VRTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | VRTX | AMGN | REGN | BMY | GSK |
| Company | Vertex Pharmaceutic | Amgen Inc | Regeneron Pharmaceuticals | Bristol-Myers Squibb Company | Gsk Plc ADR |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NYSE | NYSE |
| Open | 413.33 | 300.12 | 969.90 | 44.00 | 44.23 |
| High | 424.31 | 304.94 | 971.86 | 44.22 | 44.28 |
| Low | 412.12 | 298.89 | 961.95 | 43.74 | 44.14 |
| Last | 424.29 | 305.21 | 961.95 | 43.88 | 44.25 |
| Change | +14.05 | +4.91 | -8.02 | -0.16 | +0.10 |
| % Change | +3.42% | +1.64% | -0.83% | -0.36% | +0.23% |
| Volume | 501,571 | 531,494 | 62,819 | 1,805,214 | 365,237 |
| 20-Day Average Volume | 1,072,232 | 2,743,386 | 505,514 | 13,879,793 | 3,196,918 |
| Previous Close | 410.24 | 300.30 | 969.97 | 44.04 | 44.15 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 399.81 | 277.13 | 913.55 | 46.40 | 41.47 |
| 20-Day Raw Stochastic | 93.83% | 69.04% | 91.33% | 6.79% | 97.29% |
| 20-Day Relative Strength | 61.24% | 64.39% | 59.76% | 29.32% | 67.47% |
| Weighted Alpha | +22.26 | +30.00 | +29.57 | -36.53 | +26.60 |
| Today's Opinion | 56% Buy | 56% Buy | 72% Buy | 100% Sell | 88% Buy |
| Previous Opinion | 32% Buy | 40% Buy | 72% Buy | 100% Sell | 88% Buy |
| Last Month's Opinion | 24% Buy | 8% Sell | 40% Buy | 16% Sell | 56% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +4.72% since 05/01/24 | +9.39% since 05/01/24 | +6.64% since 05/01/24 | -0.87% since 05/01/24 | +3.81% since 05/01/24 |
| Low | 394.03 on 05/07/24 | 274.90 on 05/02/24 | 891.30 on 05/02/24 | 43.33 on 05/02/24 | 42.75 on 05/02/24 |
| High | 423.10 on 05/08/24 | 322.60 on 05/03/24 | 971.86 on 05/08/24 | 44.62 on 05/06/24 | 44.33 on 05/07/24 |
| 1-Month | |||||
| %Chg | +4.18% since 04/08/24 | +12.71% since 04/08/24 | +2.66% since 04/08/24 | -14.24% since 04/08/24 | +8.18% since 04/08/24 |
| Low | 391.01 on 04/18/24 | 260.68 on 04/19/24 | 875.22 on 04/26/24 | 43.33 on 05/02/24 | 39.15 on 04/18/24 |
| High | 423.10 on 05/08/24 | 322.60 on 05/03/24 | 971.86 on 05/08/24 | 51.68 on 04/09/24 | 44.33 on 05/07/24 |
| 3-Month | |||||
| %Chg | -0.46% since 02/08/24 | +2.91% since 02/08/24 | +1.80% since 02/08/24 | -10.03% since 02/08/24 | +5.67% since 02/08/24 |
| Low | 391.01 on 04/18/24 | 260.68 on 04/19/24 | 875.22 on 04/26/24 | 43.33 on 05/02/24 | 39.15 on 04/18/24 |
| High | 437.00 on 02/27/24 | 322.60 on 05/03/24 | 998.33 on 02/28/24 | 55.03 on 03/13/24 | 44.33 on 05/07/24 |
| 6-Month | |||||
| %Chg | +11.71% since 11/08/23 | +11.04% since 11/08/23 | +17.10% since 11/08/23 | -16.40% since 11/08/23 | +26.04% since 11/08/23 |
| Low | 341.90 on 11/16/23 | 260.52 on 11/21/23 | 783.57 on 11/10/23 | 43.33 on 05/02/24 | 33.89 on 11/10/23 |
| High | 448.40 on 01/30/24 | 329.72 on 02/05/24 | 998.33 on 02/28/24 | 55.03 on 03/13/24 | 44.33 on 05/07/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 106,030,224 | 161,091,424 | 106,465,840 | 89,273,480 | 91,498,232 |
| Shares Outstanding, K | 258,459 | 536,435 | 109,762 | 2,027,100 | 2,072,440 |
| Annual Sales | 9,869,200,000 | 28,190,000,000 | 13,117,200,000 | 45,006,000,000 | 37,725,000,000 |
| Annual Net Income | 3,619,600,000 | 6,717,000,000 | 3,953,600,000 | 8,025,000,000 | 6,129,940,000 |
| Last Quarter Sales | 2,517,700,000 | 7,447,000,000 | 3,145,000,000 | 11,865,000,000 | 9,337,020,000 |
| Last Quarter Net Income | 968,800,000 | -113,000,000 | 722,000,000 | -11,911,000,000 | 1,326,430,000 |
| 60-Month Beta | 0.39 | 0.60 | 0.17 | 0.45 | 0.65 |
| Per-Share Information | |||||
| Most Recent Earnings | 4.76 on 05/06/24 | 3.96 on 05/02/24 | 9.55 on 05/02/24 | -4.40 on 04/25/24 | 1.09 on 05/01/24 |
| Latest Earnings Date | 05/06/24 | 05/02/24 | 05/02/24 | 04/25/24 | 05/01/24 |
| Most Recent Dividend | N/A | 2.250 on 02/15/24 | N/A | 0.600 on 04/04/24 | 0.397 on 02/22/24 |
| Next Ex-Dividends Date | N/A | 05/16/24 | N/A | 04/04/24 | 05/16/24 |
| Ratios | |||||
| Price/Earnings ttm | 26.73 | 16.08 | 25.83 | 41.81 | 10.75 |